APA (7th ed.) Citation

Cheng, Z., Wang, S., Li, F., Jin, C., Mo, C., Zheng, J., . . . Gu, D. (2024). The potential adverse effects of hypodermic glucagon‐like peptide ‐1 receptor agonist on patients with type 2 diabetes: A population‐based study. Journal of Diabetes, 16(10), 1. https://doi.org/10.1111/1753-0407.70013

Chicago Style (17th ed.) Citation

Cheng, Zhiyuan, et al. "The Potential Adverse Effects of Hypodermic Glucagon‐like Peptide ‐1 Receptor Agonist on Patients with Type 2 Diabetes: A Population‐based Study." Journal of Diabetes 16, no. 10 (2024): 1. https://doi.org/10.1111/1753-0407.70013.

MLA (9th ed.) Citation

Cheng, Zhiyuan, et al. "The Potential Adverse Effects of Hypodermic Glucagon‐like Peptide ‐1 Receptor Agonist on Patients with Type 2 Diabetes: A Population‐based Study." Journal of Diabetes, vol. 16, no. 10, 2024, p. 1, https://doi.org/10.1111/1753-0407.70013.